Primary squamous cell carcinoma of the pancreas: A case report.
증례보고
1/5 보강
[INTRODUCTION] Primary squamous cell carcinoma (SCC) is a rare type of pancreatic cancer with an extremely low incidence rate and a prognosis that is poorer than that of pancreatic ductal adenocarcino
APA
Du W, Shi R, et al. (2025). Primary squamous cell carcinoma of the pancreas: A case report.. International journal of surgery case reports, 127, 110962. https://doi.org/10.1016/j.ijscr.2025.110962
MLA
Du W, et al.. "Primary squamous cell carcinoma of the pancreas: A case report.." International journal of surgery case reports, vol. 127, 2025, pp. 110962.
PMID
39870002 ↗
Abstract 한글 요약
[INTRODUCTION] Primary squamous cell carcinoma (SCC) is a rare type of pancreatic cancer with an extremely low incidence rate and a prognosis that is poorer than that of pancreatic ductal adenocarcinoma.
[PRESENTATION OF CASE] We report a case of pure pancreatic SCC in an 80-year-old man. Based on the examination before surgical resection, we did not detect any SCC lesions that might have metastasized to the pancreas. Partial gastrectomy with caudal pancreatectomy and splenectomy were performed to remove the tumor. Histopathological examination of the resected specimen confirmed the diagnosis of poorly differentiated SCC of the pancreas with stomach invasion and regional lymph node metastasis. The patient was administered adjuvant chemotherapy.
[DISCUSSION] SCC poses a diagnostic challenge, requiring histopathology for definitive diagnosis. As an aggressive disease with poor response to chemotherapy and radiotherapy, the prognosis for primary SCC is poor.
[CONCLUSION] Surgical resection and ultrasound-guided fine needle aspiration (EUS-FNA) is helpful for obtaining samples for histopathology and cytology, thus improving diagnostic accuracy.
[PRESENTATION OF CASE] We report a case of pure pancreatic SCC in an 80-year-old man. Based on the examination before surgical resection, we did not detect any SCC lesions that might have metastasized to the pancreas. Partial gastrectomy with caudal pancreatectomy and splenectomy were performed to remove the tumor. Histopathological examination of the resected specimen confirmed the diagnosis of poorly differentiated SCC of the pancreas with stomach invasion and regional lymph node metastasis. The patient was administered adjuvant chemotherapy.
[DISCUSSION] SCC poses a diagnostic challenge, requiring histopathology for definitive diagnosis. As an aggressive disease with poor response to chemotherapy and radiotherapy, the prognosis for primary SCC is poor.
[CONCLUSION] Surgical resection and ultrasound-guided fine needle aspiration (EUS-FNA) is helpful for obtaining samples for histopathology and cytology, thus improving diagnostic accuracy.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- Dual-responsive semiconducting oligomer/doxorubicin nanoplatform for photoacoustic imaging-guided synergistic chemo-photothermal therapy.
- Palmitic acid activates c-Myc via dual palmitoylation-dependent pathways to promote colon cancer.
- [Exploration and clinical application of the "digital and intelligent surgery" diagnosis and treatment workflow for oral and maxillofacial tumors].
- IL-17D promotes ferroptosis resistance in lung cancer via activating PPARγ pathway.
- Application of absorbable internal fixation system in secondary rhinoplasty of patients with unilateral cleft lip.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Acquired L858R mutation following -TKI resistance in lung adenocarcinoma: a case report.
- Multifocal anaplastic astrocytoma mimicking primary central nervous system lymphoma: A case report.
- Interleukin-11: A pivotal player and potential therapeutic target in prostate cancer.
- Multicenter Validation Study of the Clinical Diagnostic Criteria for IgG4-Related Sclerosing Cholangitis 2020 in Japan.
- Novel silicon-based material decomposition images in diagnosis of pancreatic ductal adenocarcinoma: comparison with iodine-based and 50-keV virtual monoenergetic images.
- Case Report: Secondary neurolymphomatosis successfully treated with sequential Bruton's tyrosine kinase inhibitor and bispecific antibody therapy.